-
公开(公告)号:US20170333484A1
公开(公告)日:2017-11-23
申请号:US15661281
申请日:2017-07-27
IPC分类号: A61K35/30 , A61K9/00 , C12N5/0797
CPC分类号: A61K35/30 , A61K9/0085 , C12N5/0623 , C12N2501/11 , C12N2501/113 , C12N2501/115 , C12N2501/148
摘要: The invention relates generally to methods of treating spasticity, rigidity, or muscular hyperactivity conditions by introducing a portion of an expanded population of neural stem cells into an area of a recipient spinal cord.
-
公开(公告)号:US09220730B2
公开(公告)日:2015-12-29
申请号:US13890787
申请日:2013-05-09
IPC分类号: A61K35/30 , C12N5/0797
CPC分类号: A61K35/30 , A61K9/0085 , C12N5/0623 , C12N2501/11 , C12N2501/113 , C12N2501/115 , C12N2501/148
摘要: The invention relates generally to methods of treating spasticity, rigidity, or muscular hyperactivity conditions by introducing a portion of an expanded population of neural stem cells into an area of a recipient spinal cord.
摘要翻译: 本发明一般涉及通过将一部分扩大的神经干细胞群引入受体脊髓的区域来治疗痉挛,僵硬或肌肉过度活动的方法。
-
公开(公告)号:US20130251686A1
公开(公告)日:2013-09-26
申请号:US13890787
申请日:2013-05-09
IPC分类号: A61K35/30
CPC分类号: A61K35/30 , A61K9/0085 , C12N5/0623 , C12N2501/11 , C12N2501/113 , C12N2501/115 , C12N2501/148
摘要: The invention relates generally to methods of treating spasticity, rigidity, or muscular hyperactivity conditions by introducing a portion of an expanded population of neural stem cells into an area of a recipient spinal cord.
摘要翻译: 本发明一般涉及通过将一部分扩大的神经干细胞群引入受体脊髓的区域来治疗痉挛,僵硬或肌肉过度活动的方法。
-
公开(公告)号:US10286010B2
公开(公告)日:2019-05-14
申请号:US15661281
申请日:2017-07-27
IPC分类号: C12N5/0735 , A61K35/30 , C12N5/0797 , A61K9/00
摘要: The invention relates generally to methods of treating spasticity, rigidity, or muscular hyperactivity conditions by introducing a portion of an expanded population of neural stem cells into an area of a recipient spinal cord.
-
公开(公告)号:US09744194B2
公开(公告)日:2017-08-29
申请号:US14954105
申请日:2015-11-30
IPC分类号: A61K35/30 , C12N5/0797 , A61K9/00
CPC分类号: A61K35/30 , A61K9/0085 , C12N5/0623 , C12N2501/11 , C12N2501/113 , C12N2501/115 , C12N2501/148
摘要: The invention relates generally to methods of treating spasticity, rigidity, or muscular hyperactivity conditions by introducing a portion of an expanded population of neural stem cells into an area of a recipient spinal cord.
-
公开(公告)号:US20160228471A1
公开(公告)日:2016-08-11
申请号:US14954105
申请日:2015-11-30
IPC分类号: A61K35/30 , C12N5/0797 , A61K9/00
CPC分类号: A61K35/30 , A61K9/0085 , C12N5/0623 , C12N2501/11 , C12N2501/113 , C12N2501/115 , C12N2501/148
摘要: The invention relates generally to methods of treating spasticity, rigidity, or muscular hyperactivity conditions by introducing a portion of an expanded population of neural stem cells into an area of a recipient spinal cord.
-
7.
公开(公告)号:US20170319625A1
公开(公告)日:2017-11-09
申请号:US15624959
申请日:2017-06-16
申请人: Neuralstem, Inc.
发明人: Thomas Hazel , Karl K. Johe
摘要: The present disclosure provides a human neural stem cell comprising an exogenous polynucleotide coding for a growth factor such as IGF-1. Also disclosed are methods of using the human neural stem cells for the treatment of neurodegenerative diseases or disorders including, for example, ALS.
-
公开(公告)号:US09572807B2
公开(公告)日:2017-02-21
申请号:US14740070
申请日:2015-06-15
申请人: NEURALSTEM, INC.
发明人: Karl K. Johe
IPC分类号: A61K31/496 , A61K31/444
CPC分类号: A61K31/496 , A61K31/444
摘要: Although it is known that certain benzylpiperazine-aminopyridines or open chain forms thereof are effective in stimulating neural growth in in vitro tests, it has now been surprisingly found that administering these compounds in a dosage range of 10 mg/day-130 mg/day over 25-35 days is effective in treating Major Depressive Disorder (MDD) such that statistically significant results can be obtained with samples of only six subjects.
摘要翻译: 尽管已知某些苄基哌嗪 - 氨基吡啶或其开链形式在体外试验中刺激神经生长是有效的,但是现在已经令人惊奇地发现,以10mg /天-131mg /天的剂量范围施用这些化合物, 25-35天有效治疗重度抑郁症(MDD),使得只有6名受试者的样本可获得统计学显着的结果。
-
公开(公告)号:US08674098B2
公开(公告)日:2014-03-18
申请号:US13744220
申请日:2013-01-17
申请人: Neuralstem, Inc.
IPC分类号: C07D471/00 , C07D211/32
CPC分类号: C07D239/48 , A61K31/437 , A61K31/4545 , A61K31/4985 , A61K31/505 , A61K35/12 , C07D239/49 , C07D471/04 , C07D487/04 , G01N33/5008 , G01N33/5058 , G01N33/5073 , G01N33/6896
摘要: Compositions containing neurogenic agents for inhibition of neuron death and inducing proliferation of neural cells are disclosed.
-
公开(公告)号:US10322115B2
公开(公告)日:2019-06-18
申请号:US15702162
申请日:2017-09-12
申请人: Neuralstem, Inc.
发明人: Karl K. Johe
IPC分类号: A61K31/44 , A61P25/00 , A61P25/02 , A61K31/437 , A61K31/444 , A61K31/455 , A61K31/496 , A61K31/4439
摘要: Methods for treating non-systemic deficiencies associated with diabetes using 2-amino substituted nicotinamides or their pharmaceutically acceptable salts.
-
-
-
-
-
-
-
-
-